Unknown

Dataset Information

0

Reprogramming adipose tissue-derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector.


ABSTRACT: Induced pluripotent stem (iPS) cells have great potential for personalized regenerative medicine. Although several different methods for generating iPS cells have been reported, improvement of safety and efficiency is imperative. In this study, we tested the feasibility of using a triple tyrosine mutant AAV2 (Y444+500+730F) vector, designated AAV2.3m, to generate iPS cells. We developed a polycistronic rAAV2.3m vector expressing three reprogramming factors, Klf4, Oct4, and Sox2, and then used this vector to infect mouse adipose-derived mesenchymal stem cells (AT-MSCs) to induce the generation of iPS cells. We demonstrated that (1) the triple tyrosine mutant AAV2 vector is able to reprogram mouse adult adipose tissue-derived stem cells into the pluripotent state. Those rAAV2.3m-derived iPS (rAAV2.3m-iPS) cells express endogenous pluripotency-associated genes including Oct4, Sox2, and SSEA-1, and form teratomas containing multiple tissues in vivo; (2) c-myc, an oncogene, is dispensable in rAAV2.3m-mediated cellular reprogramming; and (3) transgene expression is undetectable after reprogramming, whereas vector DNA is detectable, indicating that transgenes are silenced. These results indicated the rAAV vector may have some advantages in generating iPS cells.

SUBMITTER: Chen MJ 

PROVIDER: S-EPMC3904654 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Reprogramming adipose tissue-derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector.

Chen Mong-Jen MJ   Lu Yuanqing Y   Hamazaki Takashi T   Tsai Hsin-Yin HY   Erger Kirsten K   Conlon Thomas T   Elshikha Ahmed S AS   Li Hong H   Srivastava Arun A   Yao Chunli C   Brantly Mark M   Chiodo Vince V   Hauswirth William W   Terada Naohiro N   Song Sihong S  

Human gene therapy methods 20131228 1


Induced pluripotent stem (iPS) cells have great potential for personalized regenerative medicine. Although several different methods for generating iPS cells have been reported, improvement of safety and efficiency is imperative. In this study, we tested the feasibility of using a triple tyrosine mutant AAV2 (Y444+500+730F) vector, designated AAV2.3m, to generate iPS cells. We developed a polycistronic rAAV2.3m vector expressing three reprogramming factors, Klf4, Oct4, and Sox2, and then used th  ...[more]

Similar Datasets

| S-EPMC6115653 | biostudies-literature
| S-EPMC10579115 | biostudies-literature
| S-EPMC5310236 | biostudies-literature
| S-EPMC6076311 | biostudies-literature
| S-EPMC2787236 | biostudies-literature
| S-EPMC8422924 | biostudies-literature
| S-EPMC2567847 | biostudies-literature
| S-EPMC3561372 | biostudies-literature
| S-EPMC9331803 | biostudies-literature
| S-EPMC6403382 | biostudies-literature